Oh hell no. Not subverting them @ all. Actually, s
Post# of 148187
(Total Views: 361)
Posted On: 10/15/2024 5:44:28 PM
Oh hell no. Not subverting them @ all. Actually, some here took ditect & indirect replies to me about the FDA, for saying they are not an issue.
Soon, soon as Dr. J said we have a new, improved relationship, I said that's it. Stop bashing the FDA because you can't say you trust Dr. J., but not on "the fda". We're @ the point of you gotta trust somebody.
Said I will flop back to distrusting FDA, on Dr. J's que.
Until then, he has spoken as a goal to ease our frustrations. He's done an astounding favor to is & stood by his ethics, by addressing it head on, in the open via pr's.
Also winning the business & science respect we needed as a company. Also why others are collaborating with us, in whichever capacity they are.
I agree 100% with this:
" We had MERCK with the Keytrufa Mouse studies at MD Anderson and we have been on Gilead’s radar for sure since Covid and before that but now we have ViiV, Certainly GSK with the inventor of maraviroc at their clinical helm And PFE through the ViiV connection. You throw inJ&J because Of the Rilpivirine Connection and you have the stage for a bidding war."
I didn't highlight the Gilead total possibilities. You guys added that, & I totally forgot about them approaching the Onc cliff.
Thx in return to ya both!!
Soon, soon as Dr. J said we have a new, improved relationship, I said that's it. Stop bashing the FDA because you can't say you trust Dr. J., but not on "the fda". We're @ the point of you gotta trust somebody.
Said I will flop back to distrusting FDA, on Dr. J's que.
Until then, he has spoken as a goal to ease our frustrations. He's done an astounding favor to is & stood by his ethics, by addressing it head on, in the open via pr's.
Also winning the business & science respect we needed as a company. Also why others are collaborating with us, in whichever capacity they are.
I agree 100% with this:
" We had MERCK with the Keytrufa Mouse studies at MD Anderson and we have been on Gilead’s radar for sure since Covid and before that but now we have ViiV, Certainly GSK with the inventor of maraviroc at their clinical helm And PFE through the ViiV connection. You throw inJ&J because Of the Rilpivirine Connection and you have the stage for a bidding war."
I didn't highlight the Gilead total possibilities. You guys added that, & I totally forgot about them approaching the Onc cliff.
Thx in return to ya both!!
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼